Journal article icon

Journal article

Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.

Abstract:

Chemotherapy for platinum-resistant/refractory ovarian cancer is motivated by the hope of benefit. We sought to determine the relationships between: (a) trait hope, expectation of symptom benefit from chemotherapy, and anxiety and depression; (b) hope and perceived efficacy of chemotherapy; and (c) unfulfilled hope (where expectations for benefit are not fulfilled) and depression. Methods. Adult patients enrolled within stage 1 of the Gynecologic Cancer Intergroup Symptom Benefit Study were i...

Expand abstract

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Primary Care Health Sciences
Role:
Author
Expand authors...
Journal:
The oncologist
Volume:
18
Issue:
11
Pages:
1221-1228
Publication date:
2013-01-01
DOI:
EISSN:
1549-490X
ISSN:
1083-7159
URN:
uuid:6cebe753-2bb2-42e3-90f5-31a8fc9f3c5a
Source identifiers:
435035
Local pid:
pubs:435035

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP